Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
446.50Prev. Close
441.55Volume
0Total traded value
NAUpper Circuit
529.85Lower Circuit
353.25Fundamentals
| Market Cap | ₹2,712Cr |
| ROE | -5.22% |
| P/E Ratio(TTM) | 243.24 |
| EPS(TTM) | 1.82 |
| P/B Ratio | 3.33 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.73 |
| Book Value | 132.75 |
| Debt to Equity | 0.03 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Panacea Biotec
Panacea Biotec is a leading biotechnology company that specialises in making innovative vaccines and high-end generic medicines to address global health challenges. The company operates with the core mission of 'Innovation in Support of Life,' focusing on creating ground-breaking and affordable healthcare solutions. Demonstrating its massive scale, the company has supplied over 10 billion doses of its polio vaccine across India and other developing countries.;
| Parent Organisation | Panacea Biotec |
| Managing Director | Dr. Rajesh Jain |
| NSE Symbol | PANACEABIO |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 76.08 | ||
| Anthem Biosciences | NA (0.00%) | 90.40 | ||
| Onesource Specialty Pharma | NA (0.00%) | -1684.41 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 24.81 |